Company / Operating Income
Prime Medicine, Inc. Operating Income History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$202.5M
FY2024
5-year range
-$204.8M / -$932.0K
FY2020-FY2024
Trend
+1.1%
vs FY2023
Sector context
#141 of 202
Health Care
What the data says
At -$202M, Prime Medicine, Inc.'s operating income ranks #141 of 202 in the Health Care sector. Operating Income returned to growth in FY2024 after 3 years of decline, reaching -$202M.
Based on SEC 10-K filings.
-$202M in FY2024.
Declined from -$117M to -$202M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#141 of 202 in Health CareTop 70% of 202This company -$202.5M Sector average $70.7M
▼
-386.4% below sector average
Key checks
Key Insights
- In FY2024, operating income increased 1.1% year-over-year.
- Ranks #141 out of 202 companies in the Health Care sector.
- Peak operating income was recorded in FY2020.
- Lowest operating income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$202.5M | +1.1% |
| FY2023 | -$204.8M | -75.7% |
| FY2022 | -$116.5M | -38.0% |
| FY2021 | -$84.5M | -8963.7% |
| FY2020 | -$932.0K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026